Reports Q2 revenue $458.49M, consensus $450.78M. EPS includes the impact of the 65c per share non-cash charge related to the previously announced Genesis restructuring. Ted Wahl, CEO, stated, “Second quarter growth exceeded our expectations. New client wins and higher retention drove our organic growth, and we have carried that positive momentum into the back half of the year. Despite the previously announced Genesis news and resulting impact on our Q2 reported results, our 2025 growth plans and cash flow outlook remain strong. We are confident that continuing to execute on our strategic priorities, supported by our strong business fundamentals, will enable us to further accelerate growth, while delivering sustainable, profitable results.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCSG:
- Is HCSG a Buy, Before Earnings?
- Healthcare Services Responds to Genesis HealthCare Bankruptcy
- Healthcare Services sees 62c Q2 charge from Genesis bankruptcy
- Healthcare Services affirms 2025 revenue growth outlook of mid-single digits
- Healthcare Services down 4% after estimating Genesis bankruptcy impact